Viewing Study NCT00050050



Ignite Creation Date: 2024-05-05 @ 11:29 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00050050
Status: COMPLETED
Last Update Posted: 2014-05-26
First Post: 2002-11-20

Brief Title: Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder
Sponsor: Massachusetts General Hospital
Organization: Massachusetts General Hospital

Study Overview

Official Title: CBT for Residual ADHD Symptoms in Adults
Status: COMPLETED
Status Verified Date: 2014-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will determine the effectiveness of cognitive behavioral therapy CBT in treating the symptoms of attention deficit hyperactivity disorder ADHD in adults who have not responded to drug treatment

Study hypothesis CBT is an effective treatment for adult ADHD
Detailed Description: ADHD previously believed to be a disorder of childhood affects as many as 5 percent of adults Adults with ADHD are at high risk for academic and occupational underachievement relationship difficulties and reduced quality of life This study will determine whether CBT is more effective than drug therapy in treating ADHD symptoms in adults who have been resistant to previous drug therapies

Participants will be randomly assigned to receive 12 to 15 weekly sessions of either CBT or drug therapy which may include new or previously taken drugs Questionnaires will be used to assess participants ADHD symptoms at study start and at study completion

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
DSIR AT-AS US NIH GrantContract None httpsreporternihgovquickSearchR03MH060940
R03MH060940 NIH None None